Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

v3.24.2.u1
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)
Mar. 31, 2024
Mar. 31, 2023
Current assets:    
Cash $ 3,589,244 $ 9,352,538
VAT receivable 217,843 0
Inventories 60,383 0
Prepaid expenses and deposits 512,782 281,475
Total current assets 4,380,252 9,634,013
Non-current assets    
Right-of-use assets, net 206,090  
Property, plant & equipment, net 897,627  
Intangible software, net   178,403
Total non-current assets 1,103,717 178,403
Total assets 5,483,969 9,812,416
Current liabilities:    
Accounts payable and accrued liabilities 120,894 705,605
Current operating lease liabilities 47,955  
Accounts payable - related parties   18,296
Note payable   146,250
Deferred revenue   38,250
Total current liabilities 168,849 908,401
Non-current liabilities:    
Non-current operating lease liabilities 176,345  
Total liabilities 345,194 908,401
Commitment and contingencies (Note 15)
Stockholders' equity    
Ordinary shares, $0.001 par value, 50,000,000 shares Authorised; 2,573,903 and 1,554,709 issued and outstanding as of March 31, 2024 and 2023, respectively 2,574 1,557
Reserves 23,890,229 20,921,005
Accumulated deficit (18,527,997) (11,794,460)
Accumulated other comprehensive income (loss ) 1,951 (1,688)
Total stockholders' equity (Virax) 5,366,757 9,126,414
Non-controlling interests (227,982) (222,399)
Total stockholders' equity 5,138,775 8,904,015
Total liabilities and stockholders' equity $ 5,483,969 $ 9,812,416